Bridget E. Bunner

Array ( [id] => 4833361 [patent_doc_number] => 20080131908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'NOVEL ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE DETECTION AND DIAGNOSIS OF DISEASE' [patent_app_type] => utility [patent_app_number] => 11/874645 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16284 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131908.pdf [firstpage_image] =>[orig_patent_app_number] => 11874645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474882 [patent_doc_number] => 20100284933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Biomarkers of Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 12/445598 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19507 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284933.pdf [firstpage_image] =>[orig_patent_app_number] => 12445598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952275 [patent_doc_number] => 20110033415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'AGENT FOR DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL COMPRISING YC-1 OR IL-2 1 AND A METHOD OF DIFFERENTIATING HEMATOPOIETIC STEM CELL INTO NATURAL KILLER CELL USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/671814 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033415.pdf [firstpage_image] =>[orig_patent_app_number] => 12671814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575993 [patent_doc_number] => 20100047207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies' [patent_app_type] => utility [patent_app_number] => 12/442608 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4342 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047207.pdf [firstpage_image] =>[orig_patent_app_number] => 12442608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340087 [patent_doc_number] => 20100247551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Use of Lipocalin 2 in the Regulation of Insulin Sensitivity' [patent_app_type] => utility [patent_app_number] => 12/438632 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4313 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247551.pdf [firstpage_image] =>[orig_patent_app_number] => 12438632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8102933 [patent_doc_number] => 08153113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue' [patent_app_type] => utility [patent_app_number] => 11/894581 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 53 [patent_no_of_words] => 17505 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153113.pdf [firstpage_image] =>[orig_patent_app_number] => 11894581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771411 [patent_doc_number] => 20080057069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue' [patent_app_type] => utility [patent_app_number] => 11/894555 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 17402 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057069.pdf [firstpage_image] =>[orig_patent_app_number] => 11894555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6395282 [patent_doc_number] => 20100178271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/376591 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25710 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178271.pdf [firstpage_image] =>[orig_patent_app_number] => 12376591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879269 [patent_doc_number] => 20080152652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Ligand for the c-kit receptor and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/890212 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 34567 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152652.pdf [firstpage_image] =>[orig_patent_app_number] => 11890212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289993 [patent_doc_number] => 20090022723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'ANTI-IL-TIF ANTIBODIES AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/829765 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65121 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022723.pdf [firstpage_image] =>[orig_patent_app_number] => 11829765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 158766 [patent_doc_number] => 07674461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Anti-IL-TIF antibodies' [patent_app_type] => utility [patent_app_number] => 11/829755 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65065 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674461.pdf [firstpage_image] =>[orig_patent_app_number] => 11829755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 259730 [patent_doc_number] => 07572452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Method for stimulating wound healing' [patent_app_type] => utility [patent_app_number] => 11/829018 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6433 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572452.pdf [firstpage_image] =>[orig_patent_app_number] => 11829018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670385 [patent_doc_number] => 20080045445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Modulating Notch1 Signaling Pathway for Treating Neuroendocrine Tumors' [patent_app_type] => utility [patent_app_number] => 11/781142 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18788 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045445.pdf [firstpage_image] =>[orig_patent_app_number] => 11781142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228727 [patent_doc_number] => 07601540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Gamma secretase notch biomarkers' [patent_app_type] => utility [patent_app_number] => 11/779306 [patent_app_country] => US [patent_app_date] => 2007-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9055 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601540.pdf [firstpage_image] =>[orig_patent_app_number] => 11779306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527667 [patent_doc_number] => 08044259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Determining the capability of a test compound to affect solid tumor stem cells' [patent_app_type] => utility [patent_app_number] => 11/776935 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 66 [patent_no_of_words] => 46764 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044259.pdf [firstpage_image] =>[orig_patent_app_number] => 11776935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733832 [patent_doc_number] => 20080050811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Testicular carnitine transporter and its gene' [patent_app_type] => utility [patent_app_number] => 11/824895 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5065 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050811.pdf [firstpage_image] =>[orig_patent_app_number] => 11824895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245420 [patent_doc_number] => 20100135953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Method of treatment of age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 12/308880 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18428 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135953.pdf [firstpage_image] =>[orig_patent_app_number] => 12308880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5557754 [patent_doc_number] => 20090269331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'CASPASE-8 AND INFLAMMATION, INFECTION AND WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 12/306929 [patent_app_country] => US [patent_app_date] => 2007-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14653 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269331.pdf [firstpage_image] =>[orig_patent_app_number] => 12306929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10096963 [patent_doc_number] => 09133264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Epitope-tag surface expressed proteins and nucleic acids thereof' [patent_app_type] => utility [patent_app_number] => 12/373362 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 13040 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601271 [patent_doc_number] => 09321825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'N-terminal modified PEG-TRAIL' [patent_app_type] => utility [patent_app_number] => 12/304121 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5436 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12304121 [rel_patent_id] =>[rel_patent_doc_number] =>)